98%
921
2 minutes
20
Background: Disability is widely acknowledged as a major contributor to depression, which is a prevalent mental health condition that profoundly affects individuals, especially those with visual impairments.
Objectives: This develops a protocol for a systematic review and meta-analysis aim to examine the prevalence and incidence of depression among visually impaired people globally.
Methods: This systematic review and meta-analysis will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-P) guidelines. A thorough search will be conducted using the PubMed, MEDLINE, EMBASE, and ProQuest databases to identify relevant studies published between January 1, 2011, and August 31, 2024, without limitations on language. Two out of three independent reviewers will screen the abstracts and full-text articles, extract data, and assess the risk of bias. Heterogeneity among the included studies will be evaluated individually. Meta-analysis of the pooled prevalence and incidence estimates will be conducted using the metaprop function in StataBE 18.0. Publication bias will be assessed through funnel plot analysis and Egger's test.
Conclusion: This protocol defines the planned scope and methodology for a forthcoming systematic review and meta-analysis, which aims to provide updated evidence on the prevalence and incidence of depression among individuals with visual impairment. Accordingly, it will facilitate a systematic review and meta-analysis to address the existing research gap by providing precise estimates of the pooled prevalence and incidence of depression in this population. The findings will offer valuable insights to inform public health policy, advocate for further research, and underscore the critical need to prioritize the mental health concerns of individuals with visual impairment.
Systematic Review Registration: The protocol has been registered on the Open Science Framework (OSF) Registries with the Registration DOI: 10.17605/OSF.IO/6J4Y2.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402763 | PMC |
http://dx.doi.org/10.12688/f1000research.166020.1 | DOI Listing |
Obesity (Silver Spring)
September 2025
Division of Hematology, Oncology, and Palliative Care, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Objective: From October 18-20, 2022, the National Institutes of Health held a workshop to examine the state of the science concerning obesity interventions in adults to promote health equity. The workshop had three objectives: (1) Convene experts from key institutions and the community to identify gaps in knowledge and opportunities to address obesity, (2) generate recommendations for obesity prevention and treatment to achieve health equity, and (3) identify challenges and needs to address obesity prevalence and disparities, and develop a diverse workforce.
Methods: A three-day virtual convening.
Dan Med J
August 2025
Department of Dermatology, Zealand University Hospital, Roskilde.
Introduction: Tinea pedis is a common disease that affects up to 70% of adults during a lifetime. Most cases are caused by Trichophyton species. Worldwide, terbinafine resistance among dermatophytes is rising, which is concerning as terbinafine is the first-line treatment.
View Article and Find Full Text PDFDan Med J
August 2025
Psychiatry, Aalborg University Hospital, Aalborg.
People with severe mental illness die 10-20 years earlier than the general population, mostly from preventable physical diseases. Fragmented care, under-screening and undertreatment of cardiovascular, respiratory, infectious and cancer conditions widen this gap. Embedding physical screening, proactive treatment, smoking cessation, cancer checks and multidisciplinary, person-centred care into psychiatric services could close this mortality divide.
View Article and Find Full Text PDFDan Med J
August 2025
Department of Regional Health Research, University of Southern Denmark.
Introduction: Erysipelas is a common disease in the emergency department, whereas necrotising soft tissue infections (NSTIs) are rare but more severe. The study aimed to investigate the prevalence, incidence, population-based incidence rate, one-year mortality and clinical presentation of erysipelas and NSTIs, and the aetiology, treatment and recurrence of erysipelas.
Methods: This was a population-based cohort study including acute non-trauma patients ≥ 18 years old with erysipelas or NSTIs from the Region of Southern Denmark in the period from 1 January 2016 to 19 March 2018.
Muscle Nerve
September 2025
Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, South Korea.
Introduction/aims: There is a lack of up-to-date information on the burden of motor neuron diseases (MNDs) in the United States (US). This study aimed to estimate trends in the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) for MNDs in the US from 1990 to 2021.
Methods: We performed a secondary analysis of MNDs in the US using estimates of prevalence, incidence, and mortality obtained from analyses of the Global Burden of Disease 2021 dataset.